HRP20120187T1 - Derivati 2-oksoalkil-1-piperazin-2-ona, njihovo dobivanje i njihova upotreba u terapiji - Google Patents

Derivati 2-oksoalkil-1-piperazin-2-ona, njihovo dobivanje i njihova upotreba u terapiji Download PDF

Info

Publication number: HRP20120187T1
Authority: HR; Croatia
Prior art keywords: pyridin; dihydro; connection; oxoethyl; trifluoromethylpyridin
Prior art date: 2008-06-13

Application number

HR20120187T

Other languages

English (en)

Croatian (hr)

Inventor

Baroni Marco

Bono Fran�oise

Delbary-Gossart Sandrine

Original Assignee

Sanofi

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-13

Filing date

2009-06-12

Publication date

2012-03-31

2009-06-12 Application filed by Sanofi filed Critical Sanofi

2012-03-31 Publication of HRP20120187T1 publication Critical patent/HRP20120187T1/hr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)

HR20120187T 2008-06-13 2009-06-12 Derivati 2-oksoalkil-1-piperazin-2-ona, njihovo dobivanje i njihova upotreba u terapiji HRP20120187T1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0803298A FR2932481B1 (fr)	2008-06-13	2008-06-13	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
PCT/FR2009/051117 WO2009150387A1 (fr)	2008-06-13	2009-06-12	Derives de 2-oxo-alkyl-1-piperazin-2-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
HRP20120187T1 true HRP20120187T1 (hr)	2012-03-31

Family

ID=40305319

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20120187T HRP20120187T1 (hr)	2008-06-13	2009-06-12	Derivati 2-oksoalkil-1-piperazin-2-ona, njihovo dobivanje i njihova upotreba u terapiji

Country Status (31)

Country	Link
US (2)	US8247404B2 (sr)
EP (1)	EP2310383B8 (sr)
JP (1)	JP5476372B2 (sr)
KR (1)	KR101601999B1 (sr)
CN (1)	CN102124001B (sr)
AR (1)	AR072102A1 (sr)
AT (1)	ATE535524T1 (sr)
AU (1)	AU2009259120B2 (sr)
BR (1)	BRPI0915482B8 (sr)
CA (1)	CA2726666C (sr)
CL (1)	CL2010001432A1 (sr)
CO (1)	CO6300943A2 (sr)
CY (1)	CY1112417T1 (sr)
DK (1)	DK2310383T3 (sr)
EA (1)	EA019924B1 (sr)
ES (1)	ES2378380T3 (sr)
FR (1)	FR2932481B1 (sr)
HR (1)	HRP20120187T1 (sr)
IL (1)	IL209903A (sr)
JO (1)	JO2773B1 (sr)
MX (1)	MX2010013694A (sr)
MY (1)	MY151228A (sr)
NZ (1)	NZ589842A (sr)
PL (1)	PL2310383T3 (sr)
PT (1)	PT2310383E (sr)
RS (1)	RS52252B (sr)
SI (1)	SI2310383T1 (sr)
TW (1)	TWI400238B (sr)
UY (1)	UY31894A (sr)
WO (1)	WO2009150387A1 (sr)
ZA (1)	ZA201008791B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2932481B1 (fr)	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2932482B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75
FR2953836B1 (fr)	2009-12-14	2012-03-16	Sanofi Aventis	Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
FR2953839A1 (fr)	2009-12-14	2011-06-17	Sanofi Aventis	Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
EP2606894A1 (en)	2011-12-20	2013-06-26	Sanofi	Novel therapeutic use of p75 receptor antagonists
EP2950095B1 (en)	2014-05-28	2018-08-29	Technische Universität Dresden	Cell-based assay and screening methods for modulators of p75NTR signaling

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3236243A1 (de) *	1982-09-30	1984-04-05	Merck Patent Gmbh, 6100 Darmstadt	Schwefelhaltige indolderivate
FR2744448B1 (fr) *	1996-02-02	1998-04-24	Pf Medicament	Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
BR9810378A (pt) *	1997-07-01	2000-08-29	Novo Nordisk As	Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero
US6613942B1 (en) *	1997-07-01	2003-09-02	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
WO2000059893A1 (en)	1999-04-06	2000-10-12	Krenitsky Pharmaceuticals Inc.	Neurotrophic thio substituted pyrimidines
UA77526C2 (en) *	2002-06-07	2006-12-15	Sanofi Aventis	Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
FR2862968B1 (fr)	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique
FR2862967B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
FR2932481B1 (fr)	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2932482B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75

2008
- 2008-06-13 FR FR0803298A patent/FR2932481B1/fr not_active Expired - Fee Related
2009
- 2009-06-01 JO JO2009197A patent/JO2773B1/en active
- 2009-06-11 TW TW098119565A patent/TWI400238B/zh active
- 2009-06-11 AR ARP090102109A patent/AR072102A1/es active IP Right Grant
- 2009-06-12 BR BRPI0915482A patent/BRPI0915482B8/pt active IP Right Grant
- 2009-06-12 PL PL09761938T patent/PL2310383T3/pl unknown
- 2009-06-12 EP EP09761938A patent/EP2310383B8/fr active Active
- 2009-06-12 SI SI200930179T patent/SI2310383T1/sl unknown
- 2009-06-12 EA EA201170015A patent/EA019924B1/ru not_active IP Right Cessation
- 2009-06-12 CA CA2726666A patent/CA2726666C/fr active Active
- 2009-06-12 PT PT09761938T patent/PT2310383E/pt unknown
- 2009-06-12 CN CN200980131553.8A patent/CN102124001B/zh active Active
- 2009-06-12 UY UY0001031894A patent/UY31894A/es not_active Application Discontinuation
- 2009-06-12 NZ NZ589842A patent/NZ589842A/xx not_active IP Right Cessation
- 2009-06-12 AT AT09761938T patent/ATE535524T1/de active
- 2009-06-12 RS RS20120082A patent/RS52252B/sr unknown
- 2009-06-12 AU AU2009259120A patent/AU2009259120B2/en active Active
- 2009-06-12 WO PCT/FR2009/051117 patent/WO2009150387A1/fr not_active Ceased
- 2009-06-12 KR KR1020117000793A patent/KR101601999B1/ko active Active
- 2009-06-12 DK DK09761938.1T patent/DK2310383T3/da active
- 2009-06-12 ES ES09761938T patent/ES2378380T3/es active Active
- 2009-06-12 HR HR20120187T patent/HRP20120187T1/hr unknown
- 2009-06-12 MX MX2010013694A patent/MX2010013694A/es active IP Right Grant
- 2009-06-12 JP JP2011513037A patent/JP5476372B2/ja active Active
- 2009-06-12 MY MYPI20105853 patent/MY151228A/en unknown
2010
- 2010-12-07 ZA ZA2010/08791A patent/ZA201008791B/en unknown
- 2010-12-09 IL IL209903A patent/IL209903A/en active IP Right Grant
- 2010-12-13 CL CL2010001432A patent/CL2010001432A1/es unknown
- 2010-12-13 US US12/966,408 patent/US8247404B2/en active Active
- 2010-12-13 CO CO10156026A patent/CO6300943A2/es active IP Right Grant
2012
- 2012-02-29 CY CY20121100212T patent/CY1112417T1/el unknown
- 2012-07-24 US US13/556,328 patent/US20120289518A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CN102124001A (zh)	2011-07-13
AR072102A1 (es)	2010-08-04
TWI400238B (zh)	2013-07-01
ZA201008791B (en)	2012-02-29
NZ589842A (en)	2012-12-21
EP2310383B1 (fr)	2011-11-30
FR2932481B1 (fr)	2010-10-08
CA2726666A1 (fr)	2009-12-17
US20110144122A1 (en)	2011-06-16
EP2310383A1 (fr)	2011-04-20
US20120289518A1 (en)	2012-11-15
CY1112417T1 (el)	2015-12-09
BRPI0915482B8 (pt)	2021-05-25
KR20110031317A (ko)	2011-03-25
PL2310383T3 (pl)	2012-04-30
TW201002686A (en)	2010-01-16
AU2009259120A1 (en)	2009-12-17
CA2726666C (fr)	2016-08-16
EA201170015A1 (ru)	2011-06-30
MY151228A (en)	2014-04-30
JP5476372B2 (ja)	2014-04-23
SI2310383T1 (sl)	2012-03-30
RS52252B (sr)	2012-10-31
UY31894A (es)	2010-01-29
CO6300943A2 (es)	2011-07-21
AU2009259120B2 (en)	2014-01-16
JO2773B1 (en)	2014-03-15
KR101601999B1 (ko)	2016-03-17
CN102124001B (zh)	2014-01-22
CL2010001432A1 (es)	2011-05-13
EA019924B1 (ru)	2014-07-30
MX2010013694A (es)	2011-02-23
US8247404B2 (en)	2012-08-21
BRPI0915482B1 (pt)	2020-11-24
IL209903A0 (en)	2011-02-28
IL209903A (en)	2014-06-30
EP2310383B8 (fr)	2012-04-11
WO2009150387A1 (fr)	2009-12-17
DK2310383T3 (da)	2012-03-26
ATE535524T1 (de)	2011-12-15
FR2932481A1 (fr)	2009-12-18
JP2011522868A (ja)	2011-08-04
ES2378380T3 (es)	2012-04-11
PT2310383E (pt)	2012-03-06
BRPI0915482A2 (pt)	2015-11-10
HK1158632A1 (en)	2012-07-20

Publication	Publication Date	Title
DE60208051T2 (de)	2006-06-22	3-substituierte-4-pyrimidonderivate
CN102015635B (zh)	2013-05-08	氮杂环丁烷衍生物
CN101538254A (zh)	2009-09-23	1-哌嗪-和1-高哌嗪-羧酸酯衍生物、制备和其治疗用途
KR20100090772A (ko)	2010-08-17	단백질 키나제 억제제
JPWO2005037269A1 (ja)	2006-12-28	新規ピペリジン誘導体
US9388148B2 (en)	2016-07-12	Acylaminocycloalkyl compounds suitable for treating disorders that respond to modulation of dopamine D3 receptor
JP7684338B2 (ja)	2025-05-27	タウオリゴマーの形成を阻害する新規ベンゾフラン、ベンゾチオフェン及びインドール類似体並びにそれらの使用方法
WO2024067845A1 (zh)	2024-04-04	作为irak4降解剂的咪唑并吡啶类化合物及其用途
JP5124471B2 (ja)	2013-01-23	置換二環式ピリミドン誘導体
JP5197584B2 (ja)	2013-05-15	含窒素芳香族６員環誘導体並びにそれらを含む医薬
KR101601999B1 (ko)	2016-03-17	2-옥소-알킬-1-피페라진-2-온의 유도체, 그의 제조 방법 및 그의 치료 용도
JP5476373B2 (ja)	2014-04-23	（架橋ピペラジニル）−１−アルカノンの新規な誘導体およびｐ７５阻害剤としてのこれらの使用
JPH06509318A (ja)	1994-10-20	トロポロン誘導体ならびに虚血性疾患を予防および治療するためのその薬剤組成物
JP2009520000A (ja)	2009-05-21	カンナビノイドｃｂ１受容体モジュレーターとしての４，５−ジヒドロ−（１ｈ）−ピラゾール誘導体
JP5165578B2 (ja)	2013-03-21	イソキノリンおよびベンゾ［ｈ］イソキノリン誘導体、調製およびヒスタミンｈ３受容体のアンタゴニストとしてのこの治療上の使用
JP2025536211A (ja)	2025-11-05	神経変性疾患治療用ピペリジン尿素誘導体
KR20130082453A (ko)	2013-07-19	아밀로이드 병리의 치료 및 예방을 위한 플루페녹신 유도체
JP2007063268A (ja)	2007-03-15	医薬組成物
JP2015124211A (ja)	2015-07-06	キナゾリノン誘導体
JPH10226687A (ja)	1998-08-25	イミダゾピリジン誘導体およびその製造法
JPWO1999027965A1 (ja)	2002-09-10	抗高脂血症剤